Jeremiah Sanders
Psychiatric/Mental Health · Longview, TXNPI 1902392871
Payments from drug & device makers
Across 181 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$845
- Teva Pharmaceuticals USA, Inc.$844
- Otsuka America Pharmaceutical, Inc.$394
- Sunovion Pharmaceuticals Inc.$386
- Vanda Pharmaceuticals Inc.$374
- Alkermes, Inc.$323
- plus $1K from 12 others
What the payments were for
- Food & beverage$4,514100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $845 |
| Teva Pharmaceuticals USA, Inc. | 22 | $844 |
| Otsuka America Pharmaceutical, Inc. | 20 | $394 |
| Sunovion Pharmaceuticals Inc. | 23 | $386 |
| Vanda Pharmaceuticals Inc. | 17 | $374 |
| Alkermes, Inc. | 9 | $323 |
| Johnson & Johnson | 6 | $239 |
| AbbVie | 23 | $238 |
| Indivior Inc. | 11 | $188 |
| E.r. Squibb & Sons, L.L.C. | 3 | $178 |
| Neurocrine Biosciences, Inc. | 7 | $163 |
| Lundbeck LLC | 5 | $84 |
| Axsome Therapeutics, Inc. | 2 | $78 |
| Eisai Inc. | 4 | $67 |
| Ironshore Pharmaceuticals Inc. | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Novo Nordisk | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$436
- ARISTADA$408
- UZEDY$362
- CAPLYTA$350
- Austedo XR$228
- COBENFY$128
- Fanapt$125
- REXULTI$121
- ARISTADA INITIO$102
How this compares
$4,514 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 75 | $4,920 |
| Buprenorphine Hcl | 22 | $718 |
| Buspirone Hcl | 24 | $153 |
| Diazepam | 13 | $67 |
| Fluoxetine Hcl | 11 | $60 |
| Sertraline Hcl | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Longview
- Tracy HicksLongview$684K
- Tracy TaylorLongview$14K
- Wendy RogersLongview$13K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.